Marshall Wace North America’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Marshall Wace North America’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,978	Closed	-$1.89M	–	1725
2020 Q3	$1.89M	Sell	16,978 -4,185	-20%	-$449K	0.01%	609
2020 Q2	$2.16M	Buy	21,163 +17,607	+495%	+$1.88M	0.01%	577
2020 Q1	$384K	Buy	+3,556	New	+$409K	﹤0.01%	809
2019 Q4	–	Sell	-25,304	Closed	-$2.9M	–	1765
2019 Q3	$2.9M	Buy	+25,304	New	+$2.52M	0.02%	466
2018 Q1	–	Sell	-108,020	Closed	-$8.51M	–	1874
2017 Q4	$8.51M	Sell	108,020 -54,229	-33%	-$4.51M	0.05%	424
2017 Q3	$14.9M	Buy	+162,249	New	+$15.6M	0.09%	274
2017 Q2	–	Sell	-142,578	Closed	-$14.3M	–	1558
2017 Q1	$14.3M	Buy	+142,578	New	+$15.2M	0.11%	212

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Marshall Wace North America's CBPO Position: Q4 2020 in Review

Marshall Wace North America sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 16,978 shares — an estimated $1.89M sold.

Marshall Wace North America first reported a position in CBPO in Q1 2017 and held it in 7 quarters. The position peaked at $14.9M in Q3 2017. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Marshall Wace North America reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Marshall Wace North America sold 16,978 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $1.89M.
Marshall Wace North America first reported a position in China Biologic Products Holdings, Inc. in Q1 2017 and held it in 7 quarters.
Marshall Wace North America's China Biologic Products Holdings, Inc. position peaked at $14.9M in Q3 2017.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.